Clinical Trial Assessing Temelimab Following Rituximab Treatment in Patients With Relapsing Forms of Multiple Sclerosis

Clinical trial NCT04480307 · COMPLETED

Trial details

NCT number: NCT04480307
Sponsor: GeNeuro Innovation SAS
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Multiple Sclerosis

Start date: 2020-06-17
Primary completion: 2022-01-24
Enrollment: 41

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.